Traub-Weidinger T - Search Results

1

Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.

Traub-Weidinger T, Von Guggenberg E, Dobrozemsky G, Kendler D, Eisterer W, Bale R, Putzer D, Gabriel M, Virgolini I. Traub-Weidinger T, et al. Q J Nucl Med Mol Imaging. 2010 Feb;54(1):52-60. Q J Nucl Med Mol Imaging. 2010. PMID: 20168286 Free article. Clinical Trial.

2

Sex-specific radiomic features of L-[S-methyl-¹¹C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictability.

Papp L, Rasul S, Spielvogel CP, Krajnc D, Poetsch N, Woehrer A, Patronas EM, Ecsedi B, Furtner J, Mitterhauser M, Rausch I, Widhalm G, Beyer T, Hacker M, Traub-Weidinger T. Papp L, et al. Front Oncol. 2023 Feb 3;13:986788. doi: 10.3389/fonc.2023.986788. eCollection 2023. Front Oncol. 2023. PMID: 36816966 Free PMC article.

3

111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.

Li S, Kurtaran A, Li M, Traub-Weidinger T, Kienast O, Schima W, Angelberger P, Virgolini I, Raderer M, Dudczak R. Li S, et al. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1087-95. doi: 10.1007/s00259-003-1206-1. Epub 2003 May 24. Eur J Nucl Med Mol Imaging. 2003. PMID: 12768334 Clinical Trial.

4

Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.

Li S, Peck-Radosavljevic M, Kienast O, Preitfellner J, Havlik E, Schima W, Traub-Weidinger T, Graf S, Beheshti M, Schmid M, Angelberger P, Dudczak R. Li S, et al. Q J Nucl Med Mol Imaging. 2004 Sep;48(3):198-206. Q J Nucl Med Mol Imaging. 2004. PMID: 15499293 Free article. Clinical Trial.

5

Nuclear medicine in the detection and management of pancreatic islet-cell tumours.

Virgolini I, Traub-Weidinger T, Decristoforo C. Virgolini I, et al. Best Pract Res Clin Endocrinol Metab. 2005 Jun;19(2):213-27. doi: 10.1016/j.beem.2004.09.001. Best Pract Res Clin Endocrinol Metab. 2005. PMID: 15763696 Review.

6

Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET.

Rodrigues M, Traub-Weidinger T, Leimer M, Li S, Andreae F, Angelberger P, Dudczak R, Virgolini I. Rodrigues M, et al. Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1144-51. doi: 10.1007/s00259-005-1820-1. Epub 2005 May 21. Eur J Nucl Med Mol Imaging. 2005. PMID: 15909194 Clinical Trial.

7

Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results.

Valencak J, Heere-Ress E, Traub-Weidinger T, Raderer M, Schneeberger A, Thalhammer T, Aust S, Hamilton G, Virgolini I, Pehamberger H. Valencak J, et al. Melanoma Res. 2005 Dec;15(6):523-9. doi: 10.1097/00008390-200512000-00007. Melanoma Res. 2005. PMID: 16314738

8

Comparison of 111In-DOTA-DPhe1-Tyr3-octreotide and 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours.

Rodrigues M, Traub-Weidinger T, Li S, Ibi B, Virgolini I. Rodrigues M, et al. Eur J Nucl Med Mol Imaging. 2006 May;33(5):532-40. doi: 10.1007/s00259-005-0020-3. Epub 2006 Feb 21. Eur J Nucl Med Mol Imaging. 2006. PMID: 16491425 Clinical Trial.

9

Improved quality of life in patients treated with Peptide radionuclides.

Traub-Weidinger T, Raderer M, Uffmann M, Angelberger P, Kurtaran A, Leimer M, Preitfellner J, Dudczak R, Virgolini I. Traub-Weidinger T, et al. World J Nucl Med. 2011 Jul;10(2):115-21. doi: 10.4103/1450-1147.89779. World J Nucl Med. 2011. PMID: 22144870 Free PMC article.

10

Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide.

Putzer D, Kroiss A, Waitz D, Gabriel M, Traub-Weidinger T, Uprimny C, von Guggenberg E, Decristoforo C, Warwitz B, Widmann G, Virgolini IJ. Putzer D, et al. Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):364-72. doi: 10.1007/s00259-012-2286-6. Epub 2012 Nov 14. Eur J Nucl Med Mol Imaging. 2013. PMID: 23151915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters